Skip to main content
. 2021 Sep 2;12(11):1669–1677. doi: 10.1021/acsmedchemlett.1c00252

Scheme 1. Synthetic Pathways for (A) Triazene Derivatives 11 and 4-S-CAP (10)20 and (B) Triazene Derivatives 13af.

Scheme 1

Reagents and conditions: (A) (i) CH2Cl2, pyridine; (ii) N2 atmosphere, reflux (130 °C); (iii) conc. HCl, reflux (170 °C); (iv) THF, Et3N, rt. (B) (i) CH2Cl2, pyridine; (ii) K2CO3, THF.